MedPath

nderstanding of energy metabolism in patients with chronic liver disease (CLD) and an interventional study to assess the clinical effect of measured calorie delivery using Indirect Calorimeter versus estimated calorie delivery in ventilated patients with liver cirrhosis admitted in the IC

Not Applicable
Conditions
Health Condition 1: K721- Chronic hepatic failure
Registration Number
CTRI/2020/07/026845
Lead Sponsor
ICMR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Eligible for enteral feeding with a functional gastrointestinal tract (with or without SPN)

2.Mechanically ventilated patients expected to be on ventilator support for at least 5 days

3.Expected length of ICU stay greater than 3 days

4.Initiated on nutrition support (parenteral/or enteral nutrition)

5.The diagnosis documented by physician within one day of ICU admit

6. Signed informed consent

Exclusion Criteria

1.Active upper gastrointestinal bleeding

2.If there are conditions which precluded IC, such as an FiO2 >60 %, failure to cooperate, agitation, seizure activity, spasticity, or positive end-expiratory pressure (PEEP) >10 mmHg.

3. Pregnant women

4. Refused to consent/ inability to obtain informed consent

5.Known long standing diabetic

6. If there is any evidence of medical/surgical instability

7. Hepatocellular carcinoma Extrahepatic malignancies

8. Those receiving total parenteral (TPN)

9. With persistent gastrointestinal dysfunction and ileus

10. Readmitted to the ICU

11. Terminally ill patients on high inotropic (triple) support

12. Acute liver failure

13. If there is any evidence of medical/surgical instability

14. If patients are taking any portion of nutrition by mouth

15. Patient on CRRT- continuous renal replacement therapy for more than 48 hours oICU admission

16. Severe co morbidities such as CKD requiring maintenance dialysis, COPD ancardiac pathologies.

17.Moribund patient with likely survival <24 hours

18. Patients enrolled in other drug trials

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath